Category: Parkinson’s News

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction. Its pathological hallmark is the abnormal aggregation of α-synuclein (α-syn) …

Experts share early symptoms of Parkinson’s disease and how they vary for women. Plus get advice on managing the condition and improving quality of life.

This is the future.

A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s disease.

Since the series began in 2019, the free events have been designed to empower people with Parkinson’s and care partners to better manage the disease, learn…

/PRNewswire/ — Aspen Neuroscience, Inc. has successfully completed dose escalation and the first two cohorts of patients in the ASPIRO study, an ANPD001 Phase…

The podcast Virtually Parkinson sees AI technology synthetically recreate the late presenter’s voice and style to interview real-life celebrities, starting with R&B singer Jason Derulo.

A new study has identified polyphosphate as a likely “mystery density” within fibrils associated with Alzheimer’s and other neurodegenerative diseases. This discovery may deepen understanding of fibril roles in disease, potentially guiding new treatments, though further research is needed to confirm

Discover how global research identifies genetic variants shaping brain volume, offering insights into neurological and psychiatric disorders.

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor cortex, not direct causation. Ketamine shows promise as a treatment by disrupting abnormal brain activity and promoting long-term neuroplasticity. Researchers at the University